Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
galactose/воспаление
Ссылка сохраняется в буфер обмена
Страница 1 от 16 полученные результаты
Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The present invention relates to galactosylated pro-drugs of non-steroidal anti-inflammatories with free acid function and the process of synthesis thereof, which enables minimization of the gastrointestinal toxicity of the starting anti-inflammatory by means of esterification of its carboxylic
Disaccharide inflammation inhibitors and uses thereof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of inflammation and carbohydrate and glycoprotein chemistry. More specifically, the present invention relates to novel disaccharide inhibitors of inflammation.
2. Description of the Related
Method for preparing 3,6-anhydro-L-galactose, and use thereof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND
1. Field of the Invention
The present invention relates to 3,6-anhydro-L-galactose prepared through chemical and enzymatic methods and industrial use thereof using physiological efficacy.
2. Discussion of Related Art
Agar (or agarose) which is a main polysaccharide constituting a red alga
Method for determination of inflammatory bowel disease
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
The instant invention relates to a method for the differential diagnosis of inflammatory bowel disease. In more detail, the instant invention relates to a method for the differential diagnosis between ulcerative colitis and Crohn's disease in a patient with inflammatory bowel
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The present invention relates to novel method for designing therapeutic polypeptides for treatment of inflammatory diseases.
BACKGROUND
Although cellular receptors for immunoglobulins were first identified nearly 40 years ago, their central role in the immune response was only
Lewis-associated compound, process for producing the same, and anti-inflammatory
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
This application is filed under 35 U.S.C. .sctn.371 from International Patent Application No. PCT/JP94/00352, filed Mar. 4, 1994.
FIELD OF THE INVENTION
The present invention relates to the method for preparing Lewis-related compounds, especially Lewis x (Le.sup.x) and Lewis a (Le.sup.a) as well as
Sulfatides as anti-inflammatory compounds
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention provides methods of treatment and prevention of selectin-dependent acute lung injury and diseases which result from selectin-dependent acute lung injury by administration of a sulfatide. The present invention also provides
Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
The present invention relates to an anti-inflammatory agent, antiallergic agent, immunomodulator, cell differentiation inducer, apoptosis inducer, and a keratan sulfate oligosaccharide which is useful as an active ingredient of these pharmaceuticals.
BACKGROUND ART
Keratan sulfate is
Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
The present invention relates to an anti-inflammatory agent, antiallergic agent, immunomodulator, cell differentiation inducer, apoptosis inducer, and a keratan sulfate oligosaccharide which is useful as an active ingredient of these pharmaceuticals.
BACKGROUND ART
Keratan sulfate is
Markers for alternatively activated macrophages
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation of PCT International Patent Application No. PCT/EP2004/052076, filed on Sep. 7, 2004, designating the United States of America, and published, in English, as PCT International Publication No. WO 2005/024418 A2 on Mar. 17,
Process for the preparation of polymeric biosurfactants
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
PRIORITY CLAIM
This patent application claims priority to Indian Patent Application No. 939/DEP/2014, filed 1 Apr. 2014, the disclosure of which is incorporated herein by reference in its entirety.
FIELD OF THE INVENTION
The present invention relates to polymeric biosurfactants isolated from two
Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal antibody binding
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF INVENTION
The present invention is related to the field of cancer treatment. In one embodiment, the invention contemplates administering compounds to tumor lesions that induce local expression of .alpha.-gal epitopes within the tumor. In one embodiment, the administration induces regression
Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Phase Application of PCT/HR2014/000022, filed Jun. 11, 2014, which claims priority to Croatian Patent Application No. P20130568A, filed Jun. 20, 2013, the contents of such applications being incorporated by reference
Glycosylation-mediated inhibition of factor X
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
The invention relates to agents that inhibit the activation of Factor X, and thus are candidates for treatment or prevention of thrombosis. More specifically, the invention concerns agents that affect the normal glycosylation pattern of Factor X and thus diminish its conversion to
Glycosylation-mediated inhibition of factor X
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
The invention relates to agents that inhibit the activation of Factor X, and thus are candidates for treatment or prevention of thrombosis. More specifically, the invention concerns agents that affect the normal glycosylation pattern of Factor X and thus diminish its conversion to
Самая полная база данных о лекарственных травах, подтвержденная наукой
- Работает на 55 языках
- Травяные лекарства, подтвержденные наукой
- Распознавание трав по изображению
- Интерактивная карта GPS - отметьте травы на месте (скоро)
- Прочтите научные публикации, связанные с вашим поиском
- Ищите лекарственные травы по их действию
- Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов
Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.
